OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11
Zhi Liu, Jian Yu Chen, Zhong Yang, et al.
Brazilian Journal of Medical and Biological Research (2019) Vol. 52, Iss. 10
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Role of miRNA sponges in hepatocellular carcinoma
Dandan Li, Jiawei Zhang, Jinming Li
Clinica Chimica Acta (2019) Vol. 500, pp. 10-19
Closed Access | Times Cited: 92

A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers
Jie Xu, Xia Wang, Chunming Zhu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 40

Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xianning Dong, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 29, pp. 4240-4260
Open Access | Times Cited: 58

Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
Rana Shafabakhsh, Farzaneh Arianfar, Massoud Vosough, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 12, pp. 1229-1255
Open Access | Times Cited: 47

The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma
Yi Shi, Ji‐Bin Liu, Jing Deng, et al.
Hereditas (2021) Vol. 158, Iss. 1
Open Access | Times Cited: 44

LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
Qing Wei, Guoman Liu, Zihua Huang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1019-1035
Open Access | Times Cited: 18

Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology
Rahul Kumar Mahato, Srinjan Bhattacharya, Naina Khullar, et al.
Journal of Biotechnology (2023) Vol. 379, pp. 98-119
Closed Access | Times Cited: 17

Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 7

The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma
Gang Xu, Weiyu Xu, Yao Xiao, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 40

Long Non-Coding RNA MEG3 in Metal Carcinogenesis
Zhuo Zhang, Sophia Shi, Jingxia Li, et al.
Toxics (2023) Vol. 11, Iss. 2, pp. 157-157
Open Access | Times Cited: 15

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
Zining Li, Jialiang Gao, Di Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19

Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs
Shun Zhang, Lu Li, Jie Wang, et al.
Clinica Chimica Acta (2021) Vol. 516, pp. 100-110
Closed Access | Times Cited: 27

Mir-9-5P Promotes Cell Proliferation and Migration of Hepatocellular Carcinoma By Targeting Cpeb3
Zheyue Shu, Feng Gao, Qi Xia, et al.
Biomarkers in Medicine (2021) Vol. 15, Iss. 2, pp. 97-108
Closed Access | Times Cited: 26

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12370-12370
Open Access | Times Cited: 16

Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma
Mohamed Elzallat, Marwa Hassan, Nabila Elkramani, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15288-e15288
Open Access | Times Cited: 8

Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine
Sheng Li, Xiaoliang Cai, Liang Chen, et al.
PeerJ (2023) Vol. 11, pp. e16593-e16593
Open Access | Times Cited: 8

Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy
Xiangyuan Luo, Xiaoyu Ji, Meng Xie, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1165-1165
Open Access | Times Cited: 11

Long non‑coding RNA LINC00173 enhances cisplatin resistance in hepatocellular carcinoma via the microRNA‑641/RAB14 axis
Guang-Liang Zhao, Anhua Zhang, Shufang Sun, et al.
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 14

miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4
Kai Zhu, Jinlan Lin, Shengjia Chen, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 14

MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer
Sina Dadafarin, Tomás Rodríguez, Michelle Carnazza, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3181-3181
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top